|1|Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. (24277722)
Lastres-Becker I.... Cuadrado A.
|2|Attenuation of I^-amyloid-induced tauopathy via activation of CK2I+/SIRT1: Targeting for cilostazol. (24254769)
Lee H.R.... Kim C.D.
|3|Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach. (25225483)
Castro-Alvarez J.F.... Cardona-GA^mez G.P.
|4|Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy. (23478312)
Casarejos M.J.... Mena M.A.
|5|Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells. (24319659)
Fong H.... Huang Y.
|6|Neurodegenerative disease: can synucleinopathy and tauopathy be identified during life? (23857044)
Kubo S.... Hattori N.
|7|Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice. (24362441)
Clavaguera F.... Tolnay M.
|8|MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. (22723018)
Trabzuni D.... Ryten M.
|9|Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. (22874558)
Schaeffer V.... Goedert M.
|10|Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model. (21889983)
Yoshiyama Y.... Arai K.
|11|Potential neuroprotective strategies against tauopathy. (22817711)
Wheeler J.M.... Kraemer B.C.
|12|Impedance spectroscopy based measurement system for quantitative and label-free real-time monitoring of tauopathy in hippocampal slice cultures. (22221799)
Jahnke H.G.... Robitzki A.A.
|13|Loss of dopaminoreceptive neuron causes L-dopa resistant parkinsonism in tauopathy. (22169201)
Chiba S.... Suzuki N.
|14|Is intractable epilepsy a tauopathy? (21440375)
Xi Z.Q.... Zhu X.
|15|Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy. (21976528)
Carroll J.C.... Trojanowski J.Q.
|16|Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. (21685912)
HAPglinger G.U.... Schellenberg G.D.
|17|Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity. (20882568)
Zhao K.... D'Mello S.R.
|18|Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. (20943926)
Brunden K.R.... Trojanowski J.Q.
|19|Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies. (20569300)
Pasinetti G.M.... Ho L.
|20|Generation of tau aggregates and clearance by autophagy in an inducible cell model of tauopathy. (20173337)
Wang Y.... Mandelkow E.M.
|21|Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. (20599975)
Wills J.... Sidhu A.
|22|A novel organotypic tauopathy model on a new microcavity chip for bioelectronic label-free and real time monitoring. (20591644)
Krinke D.... Robitzki A.A.
|23|Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies. (19427527)
Luk C.... de Silva R.
|24|Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration. (19717642)
Adams S.J.... McGowan E.
|25|Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies. (19238406)
Zilka N.... Novak M.
|26|Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy. (19074615)
Dickey C.... Lewis J.
|27|Tangle-bearing neurons survive despite disruption of membrane integrity in a mouse model of tauopathy. (19535996)
de Calignon A.... Hyman B.T.
|28|Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson's disease, but not tau-containing deposits in tauopathies. (18322396)
Perry G.... Chen S.G.
|29|Functional genomics dissects pathomechanisms in tauopathies: mitosis failure and unfolded protein response. (18322384)
GAPtz J.... Ittner L.M.
|30|Hyperphosphorylated tau is a cause of neuronal dysfunction in tauopathy. (18688086)
|31|Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. (17113760)
Wen Y.... Simpkins J.W.
|32|Cytosine beta-D-arabinofuranoside used as a paradigm modifier to increase production of tau aggregates in a cellular model of tauopathy. (17151917)
Ko L.W.... Yen S.H.
|33|Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies. (17089132)
Lagalwar S.... Binder L.I.
|34|Rhodanine-based tau aggregation inhibitors in cell models of tauopathy. (17985339)
Bulic B.... Waldmann H.
|35|Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis? (17318305)
Mollenhauer B.... Otto M.
|36|TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. (16461276)
Khurana V.... Feany M.B.
|37|Neuropathology of familial tauopathy. (17080727)
|38|Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein. (17030663)
Rosenmann H.... Abramsky O.
|39|Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). (16291936)
Ramsden M.... Ashe K.H.
|40|Unique tauopathy in Fukuyama-type congenital muscular dystrophy. (16319722)
Saito Y.... Murayama S.
|41|Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies. (15372253)
Stanford P.M.... Schofield P.R.
|42|Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies. (15541003)
Maurage C.A.... Delacourte A.
|43|Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge]. (14646802)
Hauw J.J.... Duyckaerts C.
|44|Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. (14572447)
Ramakrishnan P.... Davies P.
|45|Hippocampal sclerosis dementia with tauopathy. (12946017)
Beach T.G.... Sabbagh M.
|46|Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. (11447312)
Kuusisto E.... Alafuzoff I.
|47|Analysis of tauopathies with transgenic mice. (11597522)
Hutton M.... McGowan E.
|48|The status of "Pick's Disease" and other tauopathies within the frontotemporal dementias. (11164281)
Manna D.M.... Pickering-Brown S.
|49|The molecular genetics of the tauopathies. (10959034)
van Slegtenhorst M.... Hutton M.
|50|Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. (10595524)
Ishihara T.... Lee V.M.